Coverage rules reviewed July 2026
To cover Zepbound for weight loss, most commercial plans require prior authorization documenting a BMI of 30 or higher (or 27+ with a weight-related condition such as high blood pressure or type 2 diabetes). Original Medicare and most Part D plans exclude it for weight loss by law, and many employer plans exclude weight-loss drugs entirely — so a denial is common and often appealable. Here is how each major payer handles Zepbound, and which appeal matches your denial.
What is specific to Zepbound
Zepbound has no type 2 diabetes indication — a frequent and expensive misunderstanding, since it is the same molecule as Mounjaro. When a weight-loss claim is excluded, the sleep-apnea indication is the route worth checking.
Indications other than weight loss
This is the lever most people miss. Medicare cannot pay for a drug used for weight loss — the statutory exclusion is still in force — but it can pay for a separate FDA-approved indication. The same logic applies to an employer plan that excludes weight-loss drugs. So the question is rarely “is Zepbound covered” and usually “which approved indication do I actually have?”
- Moderate-to-severe obstructive sleep apnea in adults with obesity — approved December 2024. The only non-weight indication tirzepatide carries under any brand name.
Medicare GLP-1 Bridge — includes Zepbound
Included — the KwikPen only. Vials and single-dose pens are not. Under the Bridge you pay $50 flat per one-month supply, whatever the drug or dose, from July 1, 2026 – December 31, 2027.
Type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease disqualify you — those conditions are already covered Part D indications, so the Bridge sends you there instead.
- The $50 does not count toward your deductible or out-of-pocket cap, and Extra Help does not reduce it.
- There is no appeals process — a denied prior authorization can only be resubmitted.
- It is a time-limited demonstration, not a change in the law. Medicare still excludes weight-loss drugs by statute.
- Plans do not opt in. CMS runs it outside the Part D benefit through a central processor.
- 3.8 million Medicare beneficiaries would have met the criteria in 2023 — about 8% of Part D enrollees (KFF, June 2026).
Full detail on the program: the Medicare GLP-1 Bridge explained.
The criterion payers apply to Zepbound and not its siblings
The OSA route requires a sleep study, not a symptom description: CVS Caremark asks for an apnea-hypopnea index of at least 15 per hour on polysomnography or an adequate home test. Cigna adds that central sleep apnea and Cheyne-Stokes respiration do not qualify.
Source: CVS Caremark, Zepbound initial PA with quantity limit (ref 6192-C). Criteria are the named payer's published policy and vary by plan and year.
How major insurers typically cover Zepbound
Coverage varies by your specific plan (two people with the same insurer can have different benefits), changes every year, and depends on your diagnosis. Use this as a starting point, then confirm with your plan’s current formulary.
| Insurer | Typical Zepbound coverage | Full policy |
|---|---|---|
| Aetna | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Aetna GLP-1 policy → |
| Blue Cross Blue Shield | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Blue Cross Blue Shield GLP-1 policy → |
| UnitedHealthcare | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | UnitedHealthcare GLP-1 policy → |
| Cigna | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Cigna GLP-1 policy → |
| Kaiser Permanente | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Kaiser Permanente GLP-1 policy → |
| Medicare (Part D) | Excluded for weight loss by law; may cover for a separate FDA indication (e.g. CV risk, OSA) | Medicare (Part D) GLP-1 policy → |
| Medicaid | State-dependent — only about a dozen states cover weight-loss GLP-1s (down from a 2025 peak) | Medicaid GLP-1 policy → |
Prior authorization is the norm for GLP-1s. “Covered” almost always means “covered if your plan approves a prior-authorization request.” Verify every detail against your plan’s current formulary.
How to check your Zepbound coverage
- Call the member-services number on the back of your insurance card and ask if Zepbound is on your formulary, on which tier, and what the prior-authorization criteria are.
- Search your plan’s online drug list (formulary) for Zepbound and any step-therapy or quantity limits.
- Ask your prescriber to submit a prior-authorization request with your diagnosis and supporting documentation.
- Confirm whether your plan is fully-insured or a self-funded employer (ASO) plan — employer plans often set their own GLP-1 exclusions regardless of the insurer’s logo.
If your Zepbound claim is denied
Denials are common and often reversible. Request the written denial and the cited policy, then file an internal appeal with a letter of medical necessity; you can escalate to an independent external review. Our insurance appeal letter generator builds a starting draft. If coverage truly isn’t available, compare the cheapest cash-pay routes on the Zepbound without insurance and Zepbound cost guides.
Does my insurance cover Zepbound?
Does Aetna cover Zepbound?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. If a plan refuses on the weight-loss benefit, the indication to ask about for Zepbound is moderate-to-severe obstructive sleep apnea in adults with obesity. Coverage is set by your specific plan and changes yearly, so confirm with Aetna using the number on your card. See our full Aetna GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Blue Cross Blue Shield cover Zepbound?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. If a plan refuses on the weight-loss benefit, the indication to ask about for Zepbound is moderate-to-severe obstructive sleep apnea in adults with obesity. Coverage is set by your specific plan and changes yearly, so confirm with Blue Cross Blue Shield using the number on your card. See our full Blue Cross Blue Shield GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does UnitedHealthcare cover Zepbound?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. If a plan refuses on the weight-loss benefit, the indication to ask about for Zepbound is moderate-to-severe obstructive sleep apnea in adults with obesity. Coverage is set by your specific plan and changes yearly, so confirm with UnitedHealthcare using the number on your card. See our full UnitedHealthcare GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Cigna cover Zepbound?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. If a plan refuses on the weight-loss benefit, the indication to ask about for Zepbound is moderate-to-severe obstructive sleep apnea in adults with obesity. Coverage is set by your specific plan and changes yearly, so confirm with Cigna using the number on your card. See our full Cigna GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Medicare (Part D) cover Zepbound?
Excluded for weight loss by law; may cover for a separate FDA indication (e.g. CV risk, OSA). Since July 2026 there is a second route: the Medicare GLP-1 Bridge covers Zepbound at $50 flat per one-month supply, whatever the drug or dose for members who qualify, outside the Part D benefit. Included — the KwikPen only. Vials and single-dose pens are not. Coverage is set by your specific plan and changes yearly, so confirm with Medicare (Part D) using the number on your card. See our full Medicare (Part D) GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Medicaid cover Zepbound?
State-dependent — only about a dozen states cover weight-loss GLP-1s (down from a 2025 peak). If a plan refuses on the weight-loss benefit, the indication to ask about for Zepbound is moderate-to-severe obstructive sleep apnea in adults with obesity. Coverage is set by your specific plan and changes yearly, so confirm with Medicaid using the number on your card. See our full Medicaid GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Zepbound denied by insurance: which denial did you get?
“Denied” is four different outcomes wearing the same word, and they are not appealed the same way — one of them is barely worth appealing at all. Your denial letter says which you got; the plan is required to tell you the basis in writing. Find yours below before you spend a week on the wrong fight.
Prior authorization was never submitted, or came back incomplete
How you know it's this one: The letter says "no prior authorization on file" or lists missing documentation.
What actually moves it: This is the most common denial and the least serious: nothing about your eligibility was judged. The prescriber's office submits the PA form with the diagnosis, the clinical justification, and any labs the plan asked for. Ask them to confirm it was actually filed, and to send you the plan's PA criteria for Zepbound so you can see what has to be in it.
Step therapy — the plan wants you to fail something cheaper first
How you know it's this one: The letter names another drug you must try, or says "step therapy requirement not met".
What actually moves it: You can ask for a step-therapy exception. The grounds are clinical, not financial: you have already tried the required drug, or it is contraindicated for you, or it is expected to be ineffective given your history. Your prescriber has to make that case in writing — a patient asking on their own rarely moves it. Zepbound sits at the TOP of the published ladder: Pennsylvania Medicaid requires failure of Ozempic, Wegovy and Mounjaro before approving it. That is the hardest step-therapy position of any drug here, and an exception request needs three documented trials.
The plan excludes weight-loss drugs entirely
How you know it's this one: The letter says the benefit is "not covered under your plan" rather than not medically necessary.
What actually moves it: This one is not a medical decision and an appeal usually will not move it — the employer bought a plan without the benefit. It is worth asking HR whether the exclusion has an exception process. The other route is a different diagnosis: The sleep-apnea indication is the route. With moderate-to-severe OSA and obesity the claim can go in under that instead of weight management — but it needs a sleep study showing an apnea-hypopnea index of at least 15, and Pennsylvania Medicaid additionally wants documented PAP adherence. Worth pursuing only if you have both the diagnosis and the data. Where neither applies, cash-pay is the realistic answer and pretending otherwise wastes your time.
The diagnosis or criteria on file do not meet the plan’s threshold
How you know it's this one: The letter cites BMI, A1c, or a comorbidity requirement you did not meet on paper.
What actually moves it: Often the clinical facts qualify but the paperwork did not carry them. Ask the plan, in writing, for the exact criteria it applied and the records it reviewed. If a qualifying comorbidity or a documented weight history was not in the file, that is what the appeal supplies.
How to get Zepbound covered by insurance
The mechanics — what to gather, how the appeal ladder works for your payer type, the exact Medicare Part D deadlines, and the distinction between a criteria denial you can win and a benefit exclusion you cannot — are the same for every GLP-1, so they live in one place rather than being restated on each drug page: GLP-1 insurance coverage.
The two steps worth repeating here, because they decide the rest: get the denial in writing with the criteria the plan applied (you are entitled to it, and you cannot appeal what you cannot read), and match the appeal to the denial type above — an appeal arguing medical necessity against a flat plan exclusion loses however well written. Your prescriber writes it; plans respond to clinical documentation from the prescribing office, and a patient letter is a supplement rather than the case. Appeal-letter generator.
GLP1Zoom is not an insurer, a pharmacy, or your prescriber, and none of this is legal or medical advice. Appeal rights and deadlines are set by your plan and by state and federal law — read your denial letter for yours, and confirm anything here with your plan and your clinician.
Editorial summary of how payers generally handle Zepbound — not a guarantee of coverage or medical/insurance advice. Always verify with your plan. Compare all insurer GLP-1 policies · Full disclaimer.